TWST — Twist Bioscience Balance Sheet
0.000.00%
Last trade - 00:00
- $1.62bn
- $1.30bn
- $245.11m
- 66
- 20
- 68
- 50
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 138 | 290 | 478 | 505 | 336 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 12.1 | 26.4 | 28.5 | 40.3 | 44.1 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 160 | 335 | 546 | 596 | 424 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 20.8 | 59.2 | 106 | 214 | 203 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 187 | 399 | 702 | 961 | 776 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 30.4 | 36 | 63.1 | 90.7 | 73.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 34.9 | 62.6 | 121 | 172 | 153 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 152 | 336 | 581 | 789 | 623 |
Total Liabilities & Shareholders' Equity | 187 | 399 | 702 | 961 | 776 |
Total Common Shares Outstanding |